Conversely, blocking this pathway has been shown to reduce ERS and mitigate dextran sulfate sodium–induced colitis (Fan et al., 2024), and silencing ATF4 in vitro has been found to substantially opposed H/R-induced ERS and protected cells from H/R damage (Liu et al., 2024). Here, ATF4 is linked to colitis.